Completed PHASE2 INTERVENTIONAL 2-arm NCT01328496

Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

Sponsor: Assisi Foundation

Conditions Disorder Related to Transplantation Hematologic Malignancies Hematopoietic Malignancy

Updated 7 times since 2017 Last updated: May 4, 2017 Started: Jun 15, 2011 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Disorder Related to Transplantation and Hematologic Malignancies and is currently completed. Assisi Foundation leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assisi Foundation
St. Jude Children's Research Hospital
The Hartwell Foundation

Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Memphis, United States